b
r
c
sarslik
coronaviru
slcov
bat
similar
genom
organ
human
sarscov
cognat
gene
product
highli
conserv
except
ntermin
region
protein
sequenc
ident
ntermin
region
coronaviru
protein
respons
virusreceptor
interact
studi
immunogen
slcov
protein
sl
studi
compar
sarscov
sar
dna
immun
mice
sl
elicit
high
titer
antibodi
hivpseudotyp
sl
sera
low
crossreact
neutral
activ
hivpseudotyp
sar
studi
use
wild
bat
sera
reveal
highli
like
immunodomin
epitop
overlap
major
neutral
site
slcov
protein
result
demonstr
slcov
sarscov
share
limit
number
immunogen
epitop
protein
major
neutral
epitop
substanti
differ
work
provid
use
inform
futur
develop
differenti
serolog
diagnosi
vaccin
coronavirus
differ
protein
sequenc
search
origin
sever
acut
respiratori
syndrom
coronaviru
sarscov
wild
anim
led
discoveri
sever
sarslik
cov
slcov
sever
horsesho
bat
genu
rhinolophu
china
previou
studi
show
slcov
sarscov
share
similar
genom
organ
highli
conserv
gene
product
except
spike
protein
protein
low
sequenc
ident
especi
receptor
bind
domain
rbd
locat
ntermin
region
protein
differ
sequenc
region
respons
failur
slcov
protein
sl
use
angiotens
convert
enzym
known
major
receptor
sarscov
function
receptor
sarscov
protein
sar
respons
viru
entri
induct
neutral
antibodi
mediat
mainli
rbd
aa
demonstr
previous
bat
sera
natur
infect
crossreact
fail
neutral
sarscov
therefor
develop
differenti
diagnosi
specif
vaccin
virus
necessari
import
better
understand
immunogen
sl
sar
differ
sl
sar
studi
immunogen
immunodomin
region
sl
determin
use
sera
gener
dna
immun
natur
infect
bat
data
present
use
futur
develop
diagnost
vaccin
sar
sarslik
coronavirus
cell
human
cell
line
hela
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
heatedinactiv
fetal
calf
serum
gibco
usa
sijiqi
china
hela
cell
line
stabli
express
human
protein
describ
previou
report
prepar
pseudovirus
construct
codonoptim
fulllength
gene
sarscov
bat
slcov
chimer
gene
design
cs
gene
contain
aa
replac
correspond
region
describ
previous
briefli
lg
phivluc
r
plasmid
contain
variou
gene
empti
vector
control
cotransfect
cell
cm
dish
standard
calcium
phosphat
method
pseudovirus
purifi
ultracentrifug
cell
cultur
supernat
sucros
cushion
ml
min
use
rotor
beckman
pellet
pseudovirus
dissolv
pb
store
aliquot
use
antisera
six
field
bat
sera
show
posit
neg
crossreact
sarscov
use
studi
hyperimmun
mous
sera
gener
dna
immun
plasmid
pcdna
contain
codonoptim
fulllength
gene
sarscov
slcov
two
chimer
plasmid
cs
cs
see
fig
diagram
pcdna
vector
use
neg
control
five
group
five
mice
per
group
week
old
femal
balbc
mice
immun
lg
plasmid
dna
pb
vivo
electropor
accord
publish
method
mice
immun
three
time
week
sera
collect
week
inject
right
quadricep
muscl
pair
electrod
needl
mm
apart
insert
muscl
cover
dna
inject
site
electr
puls
deliv
use
electr
puls
gener
electro
squar
porat
btx
san
diego
ca
three
puls
v
follow
three
puls
opposit
polar
deliv
inject
site
rate
one
puls
per
second
puls
last
ms
elisa
elisa
perform
stringent
condit
avoid
nonspecif
reaction
briefli
microtit
plate
coat
carbon
buffer
ph
night
purifi
pseudovirus
ngwell
plate
wash
block
bsa
tween
incub
bat
mous
sera
h
bound
antibodi
detect
use
horseradish
peroxidaseconjug
goat
antimous
igg
lingfei
tech
goat
antibat
igg
bethyl
laboratori
inc
dilut
color
develop
conduct
use
tetramethylbenzidin
tmb
absorb
nm
determin
reaction
stop
h
wash
carri
use
tween
wash
minwash
antibodi
dilut
use
bsa
tween
appropri
neg
control
includ
everi
step
neutral
assay
pseudovirusbas
neutral
assay
use
determin
neutral
abil
immun
sera
pseudoviru
hivc
neutral
activ
heatinactiv
sera
min
determin
mix
ng
pseudoviru
dilut
antisera
h
serapseudoviru
complex
mix
ng
polybren
medium
ad
human
express
hela
cell
infect
cell
wash
pb
lyse
cell
cultur
lysi
reagent
promega
h
post
infect
neutral
activ
antiserum
monitor
measur
luciferas
activ
final
boost
endpoint
dilut
elisa
use
detect
antibodi
respons
protein
immun
mice
fig
neg
control
immun
mice
produc
antibodi
pseudoviru
albeit
display
differ
reactiv
two
pseudoviru
antigen
test
pseudoviru
antisera
gener
fulllength
significantli
higher
titer
three
group
fig
also
titer
sera
two
chimer
plasmid
cs
cs
higher
construct
hand
test
pseudoviru
antibodi
titer
lowest
group
immun
plasmid
express
fulllength
protein
fig
littl
differ
titer
among
three
group
mous
sera
gener
use
dna
immun
test
abil
neutral
hivc
pseudoviru
shown
fig
mous
sera
cs
cs
show
strong
neutral
activ
pseudoviru
wherea
antiserum
show
much
weaker
neutral
activ
pseudoviru
interestingli
sera
except
vector
control
group
neutral
activ
hivc
fig
howev
serum
show
neutral
activ
hivc
high
concentr
indic
presenc
crossneutr
epitop
locat
outsid
rbd
similar
result
obtain
use
mice
sera
bat
sera
natur
infect
slcov
much
stronger
reactiv
toward
three
pseudovirus
fig
knowledg
immunogen
immunodomin
region
major
viral
antigen
import
ration
design
effect
vaccin
diagnost
test
slcov
found
bat
similar
human
isol
sarscov
almost
ident
genom
organ
gene
product
share
high
level
amino
acid
sequenc
ident
shown
previous
despit
substanti
antigen
crossreact
bat
sera
natur
infect
anim
sarscov
crossneutr
detect
discrep
could
explain
low
level
sequenc
ident
share
ntermin
domain
protein
two
class
virus
ntermin
region
coronaviru
protein
known
respons
viru
attach
suscept
host
cell
henc
major
target
neutral
antibodi
studi
dna
construct
express
four
differ
protein
sarscov
slcov
two
chimera
use
gener
hyperimmun
sera
mice
via
dna
immun
immunogen
protein
determin
use
elisa
sl
sar
protein
express
form
hiv
pseudovirus
neutral
activ
mous
sera
determin
use
hivc
pseudoviru
result
obtain
clearli
demonstr
mice
immun
cs
cs
gener
antibodi
higher
antigen
neutral
activ
hivc
vice
versa
mice
immun
display
higher
reactiv
hiv
result
demonstr
slcov
sarscov
share
limit
number
immunogen
epitop
protein
major
neutral
epitop
substanti
differ
among
two
virus
sinc
rbd
sl
protein
known
abl
conclud
whether
immunodomin
region
overlap
receptor
attach
site
reason
unabl
identifi
suitabl
suscept
cell
line
conduct
neutral
test
pseudoviru
assay
avail
imposs
conduct
detail
compar
studi
major
neutral
epitop
two
differ
virus
studi
conduct
bat
sera
four
differ
pseudovirus
provid
indirect
evid
suggest
substanti
overlap
immunodomin
neutral
epitop
sl
protein
best
demonstr
reactiv
bat
sera
pseudoviru
hivc
respect
replac
sequenc
aa
alon
almost
complet
abolish
bat
antibodi
reactiv
toward
sl
protein
varieti
slcov
cov
found
bat
demonstr
bat
natur
reservoir
divers
cov
high
densiti
bat
habitat
provid
ampl
opportun
recombin
turn
increas
viru
divers
chanc
spill
host
includ
human
lead
zoonot
diseas
outbreak
recent
shown
synthet
slcov
contain
small
fragment
sarscov
gene
abl
infect
caus
diseas
mice
highlight
potenti
emerg
novel
virus
subtl
sequenc
differ
gene
result
obtain
work
would
suggest
current
diagnost
tool
candid
vaccin
develop
sarscov
like
specif
effect
enough
combat
diseas
outbreak
caus
slcov
variant
therefor
necessari
continu
strateg
research
area
abl
rapidli
respons
diseas
outbreak
caus
coronavirus
similar
genet
pathogen
featur
differ
gene
sequenc
receptor
specif
one
neg
bat
sera
neg
determin
sarscov
previou
studi
data
present
mean
sd
